These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Lehmann M; Ghosh PM; Madison C; Laforce R; Corbetta-Rastelli C; Weiner MW; Greicius MD; Seeley WW; Gorno-Tempini ML; Rosen HJ; Miller BL; Jagust WJ; Rabinovici GD Brain; 2013 Mar; 136(Pt 3):844-58. PubMed ID: 23358601 [TBL] [Abstract][Full Text] [Related]
7. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging. Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956 [TBL] [Abstract][Full Text] [Related]
8. Resting-state functional connectivity and amyloid burden influence longitudinal cortical thinning in the default mode network in preclinical Alzheimer's disease. Hampton OL; Buckley RF; Manning LK; Scott MR; Properzi MJ; Peña-Gómez C; Jacobs HIL; Chhatwal JP; Johnson KA; Sperling RA; Schultz AP Neuroimage Clin; 2020; 28():102407. PubMed ID: 32942175 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of tau deposition using Bullich S; Mueller A; De Santi S; Koglin N; Krause S; Kaplow J; Kanekiyo M; Roé-Vellvé N; Perrotin A; Jovalekic A; Scott D; Gee M; Stephens A; Irizarry M Alzheimers Res Ther; 2022 Jul; 14(1):105. PubMed ID: 35897078 [TBL] [Abstract][Full Text] [Related]
10. Microglial activation and tau burden predict cognitive decline in Alzheimer's disease. Malpetti M; Kievit RA; Passamonti L; Jones PS; Tsvetanov KA; Rittman T; Mak E; Nicastro N; Bevan-Jones WR; Su L; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB Brain; 2020 May; 143(5):1588-1602. PubMed ID: 32380523 [TBL] [Abstract][Full Text] [Related]
11. Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease. Tanner JA; Iaccarino L; Edwards L; Asken BM; Gorno-Tempini ML; Kramer JH; Pham J; Perry DC; Possin K; Malpetti M; Mellinger T; Miller BL; Miller Z; Mundada NS; Rosen HJ; Soleimani-Meigooni DN; Strom A; La Joie R; Rabinovici GD Brain; 2022 Dec; 145(12):4489-4505. PubMed ID: 35762829 [TBL] [Abstract][Full Text] [Related]
12. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D; Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532 [TBL] [Abstract][Full Text] [Related]
13. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. Phillips JS; Das SR; McMillan CT; Irwin DJ; Roll EE; Da Re F; Nasrallah IM; Wolk DA; Grossman M Hum Brain Mapp; 2018 Feb; 39(2):691-708. PubMed ID: 29105977 [TBL] [Abstract][Full Text] [Related]
14. Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease. Ossenkoppele R; Cohn-Sheehy BI; La Joie R; Vogel JW; Möller C; Lehmann M; van Berckel BN; Seeley WW; Pijnenburg YA; Gorno-Tempini ML; Kramer JH; Barkhof F; Rosen HJ; van der Flier WM; Jagust WJ; Miller BL; Scheltens P; Rabinovici GD Hum Brain Mapp; 2015 Nov; 36(11):4421-37. PubMed ID: 26260856 [TBL] [Abstract][Full Text] [Related]
15. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals. d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals. Ingala S; Tomassen J; Collij LE; Prent N; van 't Ent D; Ten Kate M; Konijnenberg E; Yaqub M; Scheltens P; de Geus EJC; Teunissen CE; Tijms B; Wink AM; Barkhof F; van Berckel BNM; Visser PJ; den Braber A Brain Commun; 2021; 3(4):fcab201. PubMed ID: 34617016 [TBL] [Abstract][Full Text] [Related]
17. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology. Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077 [TBL] [Abstract][Full Text] [Related]
18. Association of cortical microstructure with amyloid-β and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. Rodriguez-Vieitez E; Montal V; Sepulcre J; Lois C; Hanseeuw B; Vilaplana E; Schultz AP; Properzi MJ; Scott MR; Amariglio R; Papp KV; Marshall GA; Fortea J; Johnson KA; Sperling RA; Vannini P Mol Psychiatry; 2021 Dec; 26(12):7813-7822. PubMed ID: 34588623 [TBL] [Abstract][Full Text] [Related]
19. Rates of longitudinal change in Phillips JS; Nitchie FJ; Da Re F; Olm CA; Cook PA; McMillan CT; Irwin DJ; Gee JC; Dubroff JG; Grossman M; Nasrallah IM; Alzheimers Dement; 2022 Jun; 18(6):1235-1247. PubMed ID: 34515411 [TBL] [Abstract][Full Text] [Related]